Is it time to consider oral vancomycin treatment for the management of pediatric inflammatory bowel disease irrespective of the presence of primary sclerosing cholangitis?

Marianne Samyn; Marco Gasparetto

doi:10.1002/jpn3.70431

Is it time to consider oral vancomycin treatment for the management of pediatric inflammatory bowel disease irrespective of the presence of primary sclerosing cholangitis?

Marianne Samyn
, Marco Gasparetto

Norwich Medical School

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	10.1002/jpn3.70431
Pages (from-to)	1319-1320
Number of pages	2
Journal	Journal of Pediatric Gastroenterology and Nutrition
Volume	82
Issue number	6
DOIs	https://doi.org/10.1002/jpn3.70431
Publication status	Published - 7 Apr 2026

Keywords

immunosuppression
liver
microbiome

Access to Document

10.1002/jpn3.70431

Cite this

@article{a8acbfb7de4f4dc08f2146d8ebb138e4,

title = "Is it time to consider oral vancomycin treatment for the management of pediatric inflammatory bowel disease irrespective of the presence of primary sclerosing cholangitis?",

keywords = "immunosuppression, liver, microbiome",

author = "Marianne Samyn and Marco Gasparetto",

year = "2026",

month = apr,

day = "7",

doi = "10.1002/jpn3.70431",

language = "English",

volume = "82",

pages = "1319--1320",

journal = "Journal of Pediatric Gastroenterology and Nutrition",

issn = "0277-2116",

publisher = "Wiley",

number = "6",